Anti‐D immunization rates may exceed 50% in many clinically relevant settings, despite varying widely among patient cohorts
Author:
Affiliation:
1. Department of Transfusion Medicine, NIH Clinical CenterNational Institutes of Health Bethesda Maryland USA
2. Red Cross Blood Service NSTOB, Institute Springe Springe Germany
3. Irish Blood Transfusion Service Dublin Ireland
Funder
NIH Clinical Center
Publisher
Wiley
Subject
Hematology,Immunology,Immunology and Allergy
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.15788
Reference10 articles.
1. O– product transfusion, inventory management, and utilization during shortage: the OPTIMUS study
2. Emergency transfusion of patients with unknown blood type with blood group O Rhesus D positive red blood cell concentrates: a prospective, single-centre, observational study
3. It is time to reconsider the risks of transfusing RhD negative females of childbearing potential with RhD positive red blood cells in bleeding emergencies
4. Low frequency of anti-D alloimmunization following D+ platelet transfusion: the Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study
5. LOW RATE OF RHESUS IMMUNIZATION FROM RH-INCOMPATIBLE BLOOD TRANSFUSIONS DURING LIVER AND HEART TRANSPLANT SURGERY
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. ASIAN TYPE DEL: TESTS FOR RED CELLS AND MANAGEMENTS FOR RECIPIENTS, DONORS, AND PREGNANT/POTENTIAL CHILDBEARING WOMEN;Japanese Journal of Transfusion and Cell Therapy;2024-08-26
2. DEL variants: review of molecular mechanisms, clinical consequences and molecular testing strategy;Functional & Integrative Genomics;2023-10-16
3. Serology and molecular biology of DEL: a narrative review;Annals of Blood;2023-09
4. Alloantigen Copy Number as a Critical Factor in RBC Alloimmunization;Transfusion Medicine Reviews;2023-01
5. When should RhD ‐negative recipients be spared the transfusion of DEL red cells to avoid anti‐D alloimmunization?;Transfusion;2022-09-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3